Intrapulmonary delivery of hormones
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 30, 1995
Issued Date -
N/A
app pub date -
Jul 25, 1994
filing date -
Jan 29, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method of treating human patients is provided by the intrapulmonary delivery of a pharmaceutically active hormone formulation. The formulation is automatically released from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for analyzing the inspiratory flow of a patient and after the patient is sent an audible or visual signal. Reproducible dosing is obtained by providing for automatic release in response to a measured inhalation profile. The overadministration of hormone formulations is avoided by providing a pre-programmed microprocessor designed to avoid overdosing.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully